GlucoTrack, Inc.
GCTKNASDAQHealthcare● Active
$0.56
$-0.05(-7.59%)
Market Cap$317775
P/E Ratio—
52W High$15.9
52W Low$0.431
GlucoTrack, Inc. (GCTK) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GCTK · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$2.65
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
GCTK reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 14, 2026 | — | -$2.65 | — | — | — | — |
| — Q1 FY2026 | Mar 30, 2026 | — | -$3.98 | — | — | — | — |
| — Q4 FY2025 | Nov 13, 2025 | — | -$4.64 | — | — | — | — |
| — Q3 FY2025 | Aug 14, 2025 | — | -$9.62 | — | — | — | — |
| — Q2 FY2025 | May 14, 2025 | — | -$20.36 | — | — | — | — |
| — Q1 FY2025 | Mar 27, 2025 | — | $10.00 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 14, 2024 | — | -$1089.82 | — | — | — | — |
| — Q3 FY2024 | Aug 13, 2024 | — | -$982.04 | — | — | — | — |
Q2 FY2026
May 14, 2026
EPS Actual
-$2.65
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 30, 2026
EPS Actual
-$3.98
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 13, 2025
EPS Actual
-$4.64
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 14, 2025
EPS Actual
-$9.62
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 14, 2025
EPS Actual
-$20.36
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 27, 2025
EPS Actual
$10.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024
EPS Actual
-$1089.82
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 13, 2024
EPS Actual
-$982.04
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for GCTK.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 14, 2026 | — | $0.70 | $0.67 | -4.30% |
| — Q1 FY2026 | Mar 30, 2026 | — | $0.99 | $0.76 | -23.57% |
| — Q4 FY2025 | Nov 13, 2025 | — | $5.93 | $5.67 | -4.38% |
| — Q3 FY2025 | Aug 14, 2025 | — | $5.80 | $5.72 | -1.38% |
| — Q2 FY2025 | May 14, 2025 | — | $8.76 | $8.98 | +2.51% |
| — Q1 FY2025 | Mar 27, 2025 | — | $14.54 | $13.94 | -4.13% |
| — Q4 FY2024 | Nov 14, 2024 | — | $432.00 | $370.20 | -14.31% |
| — Q3 FY2024 | Aug 13, 2024 | — | $1,356.00 | $1,762.80 | +30.00% |
Q2 FY2026-4.30%
Report Date
May 14, 2026
EPS Beat/Miss
—
Price Before
$0.70
Price After
$0.67
Q1 FY2026-23.57%
Report Date
Mar 30, 2026
EPS Beat/Miss
—
Price Before
$0.99
Price After
$0.76
Q4 FY2025-4.38%
Report Date
Nov 13, 2025
EPS Beat/Miss
—
Price Before
$5.93
Price After
$5.67
Q3 FY2025-1.38%
Report Date
Aug 14, 2025
EPS Beat/Miss
—
Price Before
$5.80
Price After
$5.72
Q2 FY2025+2.51%
Report Date
May 14, 2025
EPS Beat/Miss
—
Price Before
$8.76
Price After
$8.98
Q1 FY2025-4.13%
Report Date
Mar 27, 2025
EPS Beat/Miss
—
Price Before
$14.54
Price After
$13.94
Q4 FY2024-14.31%
Report Date
Nov 14, 2024
EPS Beat/Miss
—
Price Before
$432.00
Price After
$370.20
Q3 FY2024+30.00%
Report Date
Aug 13, 2024
EPS Beat/Miss
—
Price Before
$1,356.00
Price After
$1,762.80
Beat Rate0 / 8 quarters
Largest Move+30.00% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GCTK ends December
GlucoTrack, Inc. (GCTK) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-2.65 (in line with the analyst consensus of —). The next GCTK earnings date is expected around September 1, 2026.
Each quarter, investors track GCTK earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GCTK revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GCTK's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GCTK earnings · 4 questionsGlucoTrack, Inc.'s next earnings report is expected around September 1, 2026. GCTK typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GCTK historically reports after market close (AMC).
GCTK earnings datewhen is GCTK earningsGCTK next earnings datewhen does GCTK report earningsGCTK earnings calendar
▸ Source: FMP · GlucoTrack, Inc. SEC filings · US GAAP · GlucoTrack, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026